130 related articles for article (PubMed ID: 1572809)
1. Radiation and heat sensitivity of human T-lineage acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) clones displaying multiple drug resistance (MDR).
Uckun FM; Mitchell JB; Obuz V; Chandan-Langlie M; Min WS; Haissig S; Song CW
Int J Radiat Oncol Biol Phys; 1992; 23(1):115-25. PubMed ID: 1572809
[TBL] [Abstract][Full Text] [Related]
2. Radiation resistance in a multidrug resistant human T-cell leukemia line.
Shimm DS; Olson S; Hill AB
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):931-6. PubMed ID: 3182332
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
4. Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines.
Dufer J; Millot-Broglio C; Oum'Hamed Z; Liautaud-Roger F; Joly P; Desplaces A; Jardillier JC
Int J Cancer; 1995 Jan; 60(1):108-14. PubMed ID: 7814142
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.
Kavallaris M; Haber M; Norris MD; Pittman SM; Reed C; Stewart BW
Cancer Lett; 1990 Jun; 51(3):193-201. PubMed ID: 1972035
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia.
Holmes J; Jacobs A; Carter G; Janowska-Wieczorek A; Padua RA
Br J Haematol; 1989 May; 72(1):40-4. PubMed ID: 2736241
[TBL] [Abstract][Full Text] [Related]
8. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
Wolverton JS; Danks MK; Schmidt CA; Beck WT
Cancer Res; 1989 May; 49(9):2422-6. PubMed ID: 2539902
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
Miyachi H; Takemura Y; Kobayashi H; Ando Y
Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
[TBL] [Abstract][Full Text] [Related]
11. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
12. Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches.
Flandina C; Flugy A; Borsellino N; D'Alessandro N
J Chemother; 1996 Dec; 8(6):465-71. PubMed ID: 8981188
[TBL] [Abstract][Full Text] [Related]
13. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
Hill BT; Hosking LK
Cancer Chemother Pharmacol; 1994; 33(4):317-24. PubMed ID: 8281626
[TBL] [Abstract][Full Text] [Related]
14. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
Jiang XR; Kelsey SM; Wu YL; Newland AC
Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
[TBL] [Abstract][Full Text] [Related]
15. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Kim R; Beck WT
Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
[TBL] [Abstract][Full Text] [Related]
16. Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.
Lemoli RM; Igarashi T; Knizewski M; Acaba L; Richter A; Jain A; Mitchell D; Levy J; Gulati SC
Blood; 1993 Feb; 81(3):793-800. PubMed ID: 8427970
[TBL] [Abstract][Full Text] [Related]
17. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
Beck WT; Cirtain MC; Lefko JL
Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of methotrexate sensitivity in human leukemia cell lines by an adenosine triphosphate bioluminescence assay.
Pinzani P; Carotti S; Gerli A; Pazzagli M; Mazzei T; Mini E
Anticancer Drugs; 1997 Sep; 8(8):767-77. PubMed ID: 9396621
[TBL] [Abstract][Full Text] [Related]
19. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
[TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase G2 enhances trimetrexate cytotoxicity in CCRF-CEM cell lines sensitive and resistant to methotrexate.
Romanini A; Chou TC; Bertino JR
Adv Enzyme Regul; 1989; 28():323-33. PubMed ID: 2533849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
